Virginia Retirement Systems’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.08M | Sell |
22,230
-2,700
| -11% | -$131K | 0.01% | 553 |
|
|
2025
Q1 | $848K | Buy |
+24,930
| New | +$848K | 0.01% | 599 |
|
|
2023
Q3 | $971K | Buy |
21,400
+9,600
| +81% | +$436K | 0.01% | 516 |
|
|
2023
Q2 | $662K | Buy |
11,800
+4,400
| +59% | +$247K | 0.01% | 652 |
|
|
2023
Q1 | $335K | Buy |
+7,400
| New | +$335K | ﹤0.01% | 849 |
|
|
2022
Q4 | – | Sell |
-13,600
| Closed | -$889K | – | 1147 |
|
|
2022
Q3 | $889K | Buy |
+13,600
| New | +$889K | 0.01% | 611 |
|
|
2022
Q1 | $1.14M | Buy |
18,200
+1,100
| +6% | +$69K | 0.01% | 590 |
|
|
2021
Q4 | $1.3K | Buy |
17,100
+1,800
| +12% | +$136 | 0.01% | 562 |
|
|
2021
Q3 | $1.71M | Buy |
15,300
+8,900
| +139% | +$996K | 0.02% | 467 |
|
|
2021
Q2 | $1.04M | Sell |
6,400
-600
| -9% | -$97.1K | 0.01% | 638 |
|
|
2021
Q1 | $853K | Buy |
7,000
+2,500
| +56% | +$305K | 0.01% | 710 |
|
|
2020
Q4 | $689K | Sell |
4,500
-10,600
| -70% | -$1.62M | 0.01% | 738 |
|
|
2020
Q3 | $1.26M | Buy |
15,100
+800
| +6% | +$66.9K | 0.01% | 481 |
|
|
2020
Q2 | $1.05M | Buy |
14,300
+400
| +3% | +$29.4K | 0.01% | 540 |
|
|
2020
Q1 | $589K | Buy |
+13,900
| New | +$589K | 0.01% | 735 |
|